Skip to main content

Table 1 Clinical data at admission to the ICU, before chemotherapy, and after SHEDD-fA

From: Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane in Burkitt lymphoma with a very high risk of tumor lysis syndrome: a case series with literature review

Variable

Case 1

Case 2

At ICU admission

Before chemotherapy

After SHEDD-fA

At ICU admission

Before chemotherapy

After SHEDD-fA

PT-INR

0.98

0.99

1.02

1.74

1.35

1.28

APTT (sec)

23.7

31.1

33.9

93.2

33.2

35.0

BUN (mg/dL)

54.4

44

11.9

37.7

23.6

16.4

Creatinine (mg/dL)

1.65

0.95

0.29

2.23

1.34

0.83

Uric acid (mg/dL)

10.9

2.7

3.4

5.3

5.3

2

Potassium (mEq/L)

5.2

4.3

3.8

7.29

3.8

4.2

Phosphate (mg/dL)

3.6

3.9

3.3

12.2

2.3

2.7

LDH (IU/L)

8262

7707

9229

52,645

18,490

16,990

Lactate (mg/dL)

112

124

20

97

18

15

NAd (μg/kg/min)

0.5

0.3

0.1

0.25

Free

Free

  1. PT-INR prothrombin time-international normalized ratio, APTT activated partial thromboplastin time, BUN blood urea nitrogen, LDH lactate dehydrogenase, NAd noradrenalin